Abiraterone acetate – March 2021

• Brand names:
  • Zytiga®
• Pharmaceutical Company:
  • Janssen-Cilag Pty Ltd
• Condition/Indication: Metastatic prostate cancer
• Meeting Date: March 2021
• Public Summary Document (PSD) March 2021 PBAC Meeting
• Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 188KB)

Related Public Summary Documents

• Enzalutamide – March 2021